Squamous Cell of Head and Neck
Pathology
Invasive Lesions
- low-grade SCCA are the most common
- high-grade SCCA are 5% of the SCCA
- basal cell arise from the skin of the lip but not the vermilion (but may invade it)
- melanoma
Superficial Lesions
- CIS
- Leukoplakia
- Hyperkeratosis
- Cheilitis
Benign
- hemangiomas
- fibromas
- cysts
Various Forms of SCCA
Eponyme for Squamous Cell Carcinoma
- Marjolin's Ulcer
- SCC winthin a burn scar
- Verrucous Carcinoma
- Low-grade SCCA, exophytic & often anogenital, oral, or on the plantar surface foot with little metastatic potential
- Spindle Cell
- > 40 yo in sun exposed areas
Keratocanthoma (KA)
- originates in the pilosebaceous glands and closely and pathologically resembles squamous cell carcinoma (SCC).
- KA is reddish papules rapidly progress crateriform ulceration or keratin plug.
- KA are recurrent after surgical excision or those in which resection would result in cosmetic deformity may benefit from RT 35/15fx to 56/28fx.
Carcinoma In Situ
Bowen’s disease
- Untreated, development of invasive carcinoma is possible but uncommon.
- Unlike actinic keratosis, Bowen’s disease involve epidermal appendages, particularly the hairfollicle.
- Erythroplasia of Queyrat
- is Bowen’s disease of glans penis or vulva.
Treatment
- Surgical excision is usually preferred; however, radiation therapy may be considered as an alternative.
- 45 to 50 Gy at 2.5 to 3.5 Gy per fraction commonly employed.
- Facial lesions require 56 Gy at 2.0 Gy per fraction for improved cosmesis.
- Radiation therapy may be contraindicated for lower extremity lesions, as chronic, nonhealing ulcers are reported
Pre-malignant
Actinic Keratosis
- scaly or crusty bump
- epidermal hyperplasia and cellular atypia
Tumor Recurrence[2]
- Recurrent SCCA occurs in 15% of patients
- A minority of patients (27%) did not have an identifiable index lesion.
- most recurrent lesions are located within the lymphatic drainage of the parotid:
Local Recurrence and Metastasis
Influence of Tumor Variables on Local Recurrence and Metastasis of SCCA[6],[7]
Factor | Local Recurrence | Metastasis | Comments | |
---|---|---|---|---|
Size | size alone is not likely to be an independent factor for metastasis | |||
2 cm | 7.4% | 9.1% | ||
≥ 2 cm | 15.2% | 30.3% | ||
Thickness/ Depth of invasion | > 4-5 mm likely to have high-rate (> 15%) of regional LN | |||
< 4 mm | 5.3% | 6.7% | ||
> 4 mm | 17.2% | 45.7% | ||
Differentiation | associated with regional metastases | |||
Well Differentiated | 13.6% | 9.2% | ||
Poorly Differentiated (desmoplastic SCCA) | 28.6% | 32.9% | ||
Site | ||||
Sun-exposed | 7.9% | 5.2% | ||
Ear | 18.7% | 11.0% | high risk especially with cartilage invasion, deep invasion or poor differentiation | |
Lip | high-risk especially T3/T4 | |||
Scar Carcinoma | N/A | 37.9% | ||
Previous Treatment | 23.3% | 30.3% | higher incidence of nodal metastasis | |
Perineural Involvement | 47.2% | 47.3% | ENI recommended | |
Immunosupression | N/A | 12.9% |
Bibliography
1. O’Brien CJ. The parotid gland as a metastatic basin for cutaneous cancer. Arch Otolaryngol Head Neck Surg. 2005; 131:551-555.
2. Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer. 2006 Jun 1;106(11):2389-96. PMID: 16649220
3. Chen AM, Grekin RC, Garcia J, Bucci MK, Margolis LW.Radiation therapy for cutaneous squamous cell carcinoma involving the parotid area lymph nodes: dose and volume considerations.Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1377-80.
4. Wallace A, Morris CG, Kirwan J, Amdur RJ, Werning JW, Mendenhall WM. Radiotherapy for squamous cell carcinoma of the nasal vestibule.Am J Clin Oncol. 2007 Dec;30(6):612-6.
5. Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005. Sep;115(9):1561-7.
6. Thomas Habif, ed. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 1996.
7. Rowe DE, Carroll RJ, Day CL: J Am Acad Dermatol 26:976-990, 1992.
page revision: 60, last edited: 11 Nov 2008 15:32